Canada markets closed

Astrana Health, Inc. (3AM.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
37.20-0.20 (-0.53%)
At close: 03:29PM CEST
Full screen
Previous Close37.40
Open37.80
Bid36.80 x N/A
Ask38.40 x N/A
Day's Range37.20 - 37.80
52 Week Range27.00 - 41.60
Volume19
Avg. Volume0
Market Cap1.71B
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Astrana Health, Inc. to Participate in Upcoming Investor Conference

    Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the BofA Securities Health Care Conference, being held in Las Vegas, on Thursday, May 16, 2024, including a fireside chat at 10:00am PT. The webcast link will be available at

  • PR Newswire

    Astrana Health, Inc. Reports First Quarter 2024 Results

    Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2024.

  • PR Newswire

    Astrana Health, Inc. Schedules 2024 First Quarter Financial Results Release and Conference Call

    Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2024, after the close of the stock market on Tuesday, May 7, 2024. The Company will discuss those results on a conference call at 2:3